Gene · 2122
Papers2,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human model of primary carnitine deficiency cardiomyopathy reveals ferroptosis as a novel mechanism. | Stem Cell Reports | 2023 | 37802072 | PubTator, text mining | PubMed |
| Integrome signatures of lentiviral gene therapy for SCID-X1 patients. | Sci Adv | 2023 | 37801507 | PubTator, text mining | PubMed |
| Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma. | Signal Transduct Target Ther | 2023 | 37798292 | PubTator, text mining | PubMed |
| Insight into microRNAs' involvement in hematopoiesis: current standing point of findings. | Stem Cell Res Ther | 2023 | 37794439 | PubTator, text mining | PubMed |
| European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia. | Leukemia | 2023 | 37794101 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of gingivo-buccal oral cancer reveals two dominant cellular programs. | Cancer Sci | 2023 | 37792582 | PubTator, text mining | PubMed |
| Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. | Leukemia | 2023 | 37789148 | PubTator, text mining | PubMed |
| Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy. | Blood | 2023 | 37756525 | PubTator, text mining | PubMed |
| Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis. | Oncol Rep | 2023 | 37732539 | PubTator, text mining | PubMed |
| Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD. | Mol Ther | 2023 | 37705244 | PubTator, text mining | PubMed |
| Development of an in vitro genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants. | Mol Ther Methods Clin Dev | 2023 | 37693949 | PubTator, text mining | PubMed |
| The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing. | Int J Mol Sci | 2023 | 37685987 | PubTator, text mining | PubMed |
| Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia. | Sci Rep | 2023 | 37684299 | PubTator, text mining | PubMed |
| Shared and distinct genetic etiologies for different types of clonal hematopoiesis. | Nat Commun | 2023 | 37684235 | PubTator, text mining | PubMed |
| GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification. | Nat Genet | 2023 | 37679419 | PubTator, text mining | PubMed |
| Determinants of motor neuron functional subtypes important for locomotor speed. | Cell Rep | 2023 | 37676768 | PubTator, text mining | PubMed |
| Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia. | Blood Cancer J | 2023 | 37673866 | PubTator, text mining | PubMed |
| Natural Products Treat Colorectal Cancer by Regulating miRNA. | Pharmaceuticals (Basel) | 2023 | 37631037 | PubTator, text mining | PubMed |
| Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms. | Int J Mol Sci | 2023 | 37628880 | PubTator, text mining | PubMed |
| The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis. | Biomolecules | 2023 | 37627314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2122/papers?page=11